Wnt signaling has been widely implicated in cancer, especially colorectal cancer, in which mutation of key regulatory factors of the Wnt pathway (mainly APC and CTNNB1), was found in ninety percent of tumors, resulting in activation of the Wnt pathway [57–58]. Here, CTNNB1 is linked to cancer.